A detailed history of Barclays PLC transactions in Zoetis Inc. stock. As of the latest transaction made, Barclays PLC holds 1,531,712 shares of ZTS stock, worth $252 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,531,712
Previous 1,531,712 -0.0%
Holding current value
$252 Million
Previous $299 Million -0.0%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$172.58 - $196.48 $54.4 Million - $62 Million
315,495 Added 25.94%
1,531,712 $299 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $27.3 Million - $33.5 Million
-187,296 Reduced 13.34%
1,216,217 $211 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $65.2 Million - $78.6 Million
393,273 Added 38.93%
1,403,513 $237 Million
Q4 2023

Feb 15, 2024

SELL
$151.44 - $200.09 $38.6 Million - $51.1 Million
-255,144 Reduced 20.16%
1,010,240 $199 Million
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $66.8 Million - $77 Million
399,510 Added 46.14%
1,265,384 $220 Million
Q2 2023

Aug 03, 2023

BUY
$160.94 - $186.23 $71.9 Million - $83.1 Million
446,485 Added 106.46%
865,874 $149 Million
Q1 2023

May 04, 2023

SELL
$145.48 - $175.02 $50.2 Million - $60.4 Million
-345,265 Reduced 45.15%
419,389 $69.8 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $18.5 Million - $22.2 Million
141,270 Added 22.66%
764,654 $112 Million
Q3 2022

Nov 03, 2022

BUY
$148.29 - $182.55 $11.1 Million - $13.7 Million
74,892 Added 13.65%
623,384 $92.4 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $18.6 Million - $23.8 Million
-119,071 Reduced 17.84%
548,492 $94.3 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $81.2 Million - $105 Million
-447,591 Reduced 40.14%
667,563 $126 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $40.5 Million - $51.6 Million
209,028 Added 23.07%
1,115,154 $272 Million
Q3 2021

Nov 09, 2021

BUY
$189.29 - $209.69 $49.1 Million - $54.4 Million
259,494 Added 40.13%
906,126 $176 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $6.6 Million - $7.96 Million
42,323 Added 7.0%
646,632 $121 Million
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $45.4 Million - $53.4 Million
-315,008 Reduced 34.27%
604,309 $95.2 Million
Q4 2020

Feb 11, 2021

SELL
$157.07 - $174.35 $157 Million - $174 Million
-1,000,232 Reduced 52.11%
919,317 $152 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $156 Million - $188 Million
1,138,952 Added 145.91%
1,919,549 $317 Million
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $5.72 Million - $7.28 Million
-51,098 Reduced 6.14%
780,597 $107 Million
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $1.42 Million - $2.22 Million
15,318 Added 1.88%
831,695 $97.9 Million
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $8.87 Million - $10.2 Million
76,327 Added 10.31%
816,377 $108 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $8.02 Million - $9.15 Million
71,214 Added 10.65%
740,050 $92.2 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $3.09 Million - $3.61 Million
31,567 Added 4.95%
668,836 $75.9 Million
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $22 Million - $27.1 Million
-269,639 Reduced 29.73%
637,269 $64.2 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $8.45 Million - $10.2 Million
106,584 Added 13.32%
906,908 $77.6 Million
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $1.11 Million - $1.24 Million
13,318 Added 1.69%
800,324 $73.3 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $9.69 Million - $10.8 Million
-121,339 Reduced 13.36%
787,006 $67 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $2.75 Million - $3.26 Million
38,465 Added 4.42%
908,345 $75.9 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $25.9 Million - $29.8 Million
-409,993 Reduced 32.03%
869,880 $62.7 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $76.4 Million - $83.7 Million
1,279,873
1,279,873 $81.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.